National Health Investors Inc (NYSE:NHI) has been assigned a consensus rating of “Hold” from the thirteen research firms that are currently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating on the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $76.57.
A number of equities analysts have recently commented on the company. Mizuho reaffirmed a “hold” rating and issued a $70.00 price target on shares of National Health Investors in a report on Monday, February 26th. Stifel Nicolaus set a $76.00 price target on National Health Investors and gave the stock a “buy” rating in a report on Saturday, February 17th. SunTrust Banks set a $70.00 price target on National Health Investors and gave the stock a “hold” rating in a report on Saturday, February 17th. They noted that the move was a valuation call. Hilliard Lyons raised National Health Investors from a “neutral” rating to a “buy” rating in a report on Friday, February 16th. Finally, Cantor Fitzgerald reaffirmed a “hold” rating and issued a $85.00 price target on shares of National Health Investors in a report on Friday, February 16th.
In other National Health Investors news, VP John L. Spaid acquired 500 shares of the stock in a transaction that occurred on Thursday, February 22nd. The shares were bought at an average price of $64.95 per share, for a total transaction of $32,475.00. Following the completion of the transaction, the vice president now owns 971 shares of the company’s stock, valued at approximately $63,066.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO D. Eric Mendelsohn acquired 2,000 shares of the stock in a transaction that occurred on Thursday, February 22nd. The stock was acquired at an average price of $65.47 per share, for a total transaction of $130,940.00. Following the transaction, the chief executive officer now directly owns 10,580 shares of the company’s stock, valued at approximately $692,672.60. The disclosure for this purchase can be found here. Insiders purchased 2,812 shares of company stock worth $183,910 in the last quarter. 5.19% of the stock is currently owned by company insiders.
National Health Investors (NYSE NHI) traded up $0.98 during trading on Wednesday, hitting $68.30. The stock had a trading volume of 240,957 shares, compared to its average volume of 307,860. National Health Investors has a 52-week low of $62.71 and a 52-week high of $81.60. The company has a quick ratio of 13.85, a current ratio of 13.85 and a debt-to-equity ratio of 0.87. The company has a market capitalization of $2,840.00, a price-to-earnings ratio of 17.60, a P/E/G ratio of 3.44 and a beta of 0.48.
National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Friday, February 16th. The real estate investment trust reported $0.90 EPS for the quarter, missing the Zacks’ consensus estimate of $1.33 by ($0.43). National Health Investors had a return on equity of 12.20% and a net margin of 57.19%. The company had revenue of $71.06 million during the quarter, compared to the consensus estimate of $71.36 million. research analysts forecast that National Health Investors will post 5.49 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 10th. Investors of record on Friday, March 30th will be given a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a dividend yield of 5.86%. The ex-dividend date is Wednesday, March 28th. This is an increase from National Health Investors’s previous quarterly dividend of $0.95. National Health Investors’s dividend payout ratio (DPR) is 97.94%.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.